These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 8328738

  • 1. Renal mechanism of trimethoprim-induced hyperkalemia.
    Velázquez H, Perazella MA, Wright FS, Ellison DH.
    Ann Intern Med; 1993 Aug 15; 119(4):296-301. PubMed ID: 8328738
    [Abstract] [Full Text] [Related]

  • 2. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia.
    Greenberg S, Reiser IW, Chou SY, Porush JG.
    Ann Intern Med; 1993 Aug 15; 119(4):291-5. PubMed ID: 8328737
    [Abstract] [Full Text] [Related]

  • 3. Hyperkalemia with high-dose trimethoprim-sulfamethoxazole therapy.
    Greenberg S, Reiser IW, Chou SY.
    Am J Kidney Dis; 1993 Oct 15; 22(4):603-6. PubMed ID: 8213804
    [Abstract] [Full Text] [Related]

  • 4. A mechanism for pentamidine-induced hyperkalemia: inhibition of distal nephron sodium transport.
    Kleyman TR, Roberts C, Ling BN.
    Ann Intern Med; 1995 Jan 15; 122(2):103-6. PubMed ID: 7992983
    [Abstract] [Full Text] [Related]

  • 5. Trimethoprim-sulfamethoxazole: hyperkalemia is an important complication regardless of dose.
    Perazella MA, Mahnensmith RL.
    Clin Nephrol; 1996 Sep 15; 46(3):187-92. PubMed ID: 8879854
    [Abstract] [Full Text] [Related]

  • 6. Trimethoprim-sulfamethoxazole therapy in outpatients: is hyperkalemia a significant problem?
    Alappan R, Buller GK, Perazella MA.
    Am J Nephrol; 1999 Sep 15; 19(3):389-94. PubMed ID: 10393376
    [Abstract] [Full Text] [Related]

  • 7. Hyperkalemia in hospitalized patients treated with trimethoprim-sulfamethoxazole.
    Alappan R, Perazella MA, Buller GK.
    Ann Intern Med; 1996 Feb 01; 124(3):316-20. PubMed ID: 8554227
    [Abstract] [Full Text] [Related]

  • 8.
    Shrimanker I, Bhattarai S.
    ; 2024 01 01. PubMed ID: 31082167
    [Abstract] [Full Text] [Related]

  • 9. Impact of trimethoprim on serum creatinine, sodium, and potassium concentrations in patients taking trimethoprim-sulfamethoxazole without changes in glomerular filtration rate.
    Yokoyama S, Nakagawa J, Aiuchi N, Seito T, Niioka T.
    J Clin Pharm Ther; 2022 Sep 01; 47(9):1409-1417. PubMed ID: 35545234
    [Abstract] [Full Text] [Related]

  • 10. Reversal of trimethoprim-induced antikaliuresis.
    Reiser IW, Chou SY, Brown MI, Porush JG.
    Kidney Int; 1996 Dec 01; 50(6):2063-9. PubMed ID: 8943491
    [Abstract] [Full Text] [Related]

  • 11. Hyperkalemia and high-dose trimethoprim/sulfamethoxazole.
    Hsu I, Wordell CJ.
    Ann Pharmacother; 1995 Apr 01; 29(4):427-9. PubMed ID: 7633023
    [Abstract] [Full Text] [Related]

  • 12. Mineralocorticoid-resistant renal hyperkalemia without salt wasting (type II pseudohypoaldosteronism): role of increased renal chloride reabsorption.
    Schambelan M, Sebastian A, Rector FC.
    Kidney Int; 1981 May 01; 19(5):716-27. PubMed ID: 7026872
    [Abstract] [Full Text] [Related]

  • 13. University of Miami Division of Clinical Pharmacology therapeutic rounds: drug-induced hyperkalemia.
    Preston RA, Hirsh MJ MD, Oster MD, Oster HR MD.
    Am J Ther; 1998 Mar 01; 5(2):125-32. PubMed ID: 10099101
    [Abstract] [Full Text] [Related]

  • 14. Differential acute effects of aldosterone, dexamethasone, and hyperkalemia on distal tubular potassium secretion in the rat kidney.
    Field MJ, Stanton BA, Giebisch GH.
    J Clin Invest; 1984 Nov 01; 74(5):1792-802. PubMed ID: 6501571
    [Abstract] [Full Text] [Related]

  • 15. Brief report: trimethoprim-induced hyperkalemia in a patient with AIDS.
    Choi MJ, Fernandez PC, Patnaik A, Coupaye-Gerard B, D'Andrea D, Szerlip H, Kleyman TR.
    N Engl J Med; 1993 Mar 11; 328(10):703-6. PubMed ID: 8433730
    [No Abstract] [Full Text] [Related]

  • 16. Studies on the mechanism of trimethoprim-induced hyperkalemia.
    Eiam-Ong S, Kurtzman NA, Sabatini S.
    Kidney Int; 1996 May 11; 49(5):1372-8. PubMed ID: 8731102
    [Abstract] [Full Text] [Related]

  • 17. A micropuncture study of potassium excretion by the remnant kidney.
    Bank N, Aynedjian HS.
    J Clin Invest; 1973 Jun 11; 52(6):1480-90. PubMed ID: 4703232
    [Abstract] [Full Text] [Related]

  • 18. Trimethoprim-induced hyperkalaemia: clinical data, mechanism, prevention and management.
    Perazella MA.
    Drug Saf; 2000 Mar 11; 22(3):227-36. PubMed ID: 10738846
    [Abstract] [Full Text] [Related]

  • 19. Pseudohypoaldosteronism type II: proximal renal tubular acidosis and dDAVP-sensitive renal hyperkalemia.
    Nahum H, Paillard M, Prigent A, Leviel F, Bichara M, Gardin JP, Idatte JM.
    Am J Nephrol; 1986 Mar 11; 6(4):253-62. PubMed ID: 3777034
    [Abstract] [Full Text] [Related]

  • 20. Trimethoprim-associated hyponatremia.
    Babayev R, Terner S, Chandra S, Radhakrishnan J, Mohan S.
    Am J Kidney Dis; 2013 Dec 11; 62(6):1188-92. PubMed ID: 23891358
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.